Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-05-16
1991-11-12
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 81, 514211, 540490, 540487, 540502, A61K 3155, C07D48722
Patent
active
050648250
ABSTRACT:
Novel substituted imidazo-fused 7-member ring heterocycles of the formulae (I) and (Ia), which are useful as angiotensin II antagonists, are disclosed. ##STR1##
REFERENCES:
patent: 4207324 (1980-06-01), Matsumura et al.
patent: 4340598 (1982-07-01), Furukawa et al.
patent: 4576958 (1986-03-01), Wexler
patent: 4582847 (1986-04-01), Furukawa et al.
P. G. Wong et al., J. Pharmcol. Exp. Ther., "Nonpeptide Angiotension II Receptor Antagonists", 247(1), pp. 1-(1988).
P. K. Bridson et al., Journal of Heterocyclic Chemistry, "Cyclic Homologs of Xanthins", 25(4), pp. 1179-1182 (1988).
Chakravarty Prasun K.
Greenlee William J.
Mantlo Nathan B.
Patchett Arthur A.
Schoen William
DiPrima Joseph F.
Merck & Co. , Inc.
Nicholson William H.
Raymond Richard L.
Russell Mark W.
LandOfFree
Angiotensin II antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1013254